Literature DB >> 8164430

Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease.

K Earle1, G C Viberti.   

Abstract

Proteinuric diabetic patients have an increased risk of cardiovascular disease and almost always have hypertension. In the early stages of diabetic renal disease (microalbuminuria) when renal function is well preserved, systemic arterial blood pressure is already elevated compared to insulin-dependent diabetic patients without microalbuminuria. Prospective studies have shown that normoalbuminuric patients who progress to microalbuminuria have higher blood pressures (albeit within the normal range) than those who persistently remain normoalbuminuric. Parents of insulin-dependent diabetic patients with nephropathy have a higher prevalence of hypertension and cardiovascular disease compared to those of patients without nephropathy. Moreover, diabetic nephropathy clusters within families. Erythrocyte sodium-lithium countertransport activity, the most consistent marker for essential hypertension and its cardiorenal complications, is elevated in diabetic patients with nephropathy and in their non-diabetic parents. These data suggest that a familial predisposition to arterial hypertension and cardiovascular disease increases the risk for the development of nephropathy and its associated cardiovascular complications in insulin-dependent diabetes. Arterial hypertension is a state of insulin resistance and diabetic patients susceptible to nephropathy have been found to be less insulin sensitive. Preventive strategies of diabetic kidney disease in the future will have to take into account its metabolic hemodynamic and familial basis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164430     DOI: 10.1038/ki.1994.56

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Is it possible to predict diabetic kidney disease?

Authors:  S M Thomas; G C Viberti
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.

Authors:  Olugbenga E Ayodele; C Olutayo Alebiosu; Babatunde L Salako
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

3.  Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.

Authors:  Brad P Dieter; Sterling M McPherson; Maryam Afkarian; Ian H de Boer; Rajnish Mehrotra; Robert Short; Celestina Barbosa-Leiker; Radica Z Alicic; Rick L Meek; Katherine R Tuttle
Journal:  J Diabetes Complications       Date:  2016-07-27       Impact factor: 2.852

4.  Arterial hypertension in diabetes mellitus: from theory to clinical practice.

Authors:  C Sampanis; C Zamboulis
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

5.  Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.

Authors: 
Journal:  BMJ       Date:  1995-10-14

6.  A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes.

Authors:  Mian Wu; Junxi Lu; Lei Zhang; Fengjing Liu; Si Chen; Ying Han; Fangya Zhao; Kaifeng Guo; Yuqian Bao; Haibing Chen; Weiping Jia
Journal:  Oncotarget       Date:  2017-10-09

7.  The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus.

Authors:  Jorge Andrade-Sierra; Leonardo Pazarín-Villaseñor; Francisco Gerardo Yanowsky-Escatell; Elodia Nataly Díaz-de la Cruz; Andrés García-Sánchez; Ernesto Germán Cardona-Muñoz; Francisco Javier Munguía-Galaviz; Alejandra de Alba-Razo; Alejandra Guillermina Miranda-Díaz
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

8.  Renal function and hemodynamic study in obese Zucker rats.

Authors:  S K Park; S K Kang
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.